Home Drug Injury Rezulin Liver Damage Settlement

Rezulin Liver Damage Settlement

Rezulin (troglitazone) was a “new” type of antidiabetic medication introduced in 1997 to treat Type 2 diabetes. Originally rejected due to concerns about liver damage, the drug was approved for the market in March 1997, only to be withdrawn in March 2000 due to at least 430 cases of liver failure being reported in patients. Seeger Weiss was a court-appointed member of the Plaintiffs’ Executive Committee, and the firm played a pivotal role in securing an estimated $750 million on behalf of patients who were harmed after taking Rezulin.

Resolved

Prior results do not guarantee or predict a similar outcome in any future matter.

Last updated: Jul 28, 2025
Rezulin Liver Damage Lawsuit Settlement

What’s on this page:

Firm News

June 2, 2026
Seeger Weiss Appointed Interim Co-Lead Counsel and Lead Settlement Counsel in Consumer Class Action Against Huel Protein Powder

Seeger Weiss has been appointed interim Co-Lead Counsel and interim Lead Settlement Counsel in In re Huel Heavy Metal Litigation, a consolidated consumer class action pending in the Eastern District of New York. The litigation alleges that Huel, Inc. and Huel, Ltd. engaged in fraudulent marketing of their “Huel Black Edition” protein powder product. Plaintiffs […]

Read More
June 1, 2026
First Social Media Addiction MDL Bellwether Trial Settlement

Meta, Snap, TikTok, and YouTube have each agreed to settle claims brought by a County School District in Kentucky, resolving the first bellwether school district case in the Social Media Adolescent Addiction/Personal Injury Products Liability MDL. The trial had been scheduled to begin in June in the U.S. District Court in Oakland, California. Seeger Weiss […]

Read More
June 1, 2026
Seeger Weiss Named Finalist for Seven Categories in the National Law Journal’s 2026 Elite Trial Lawyers Awards

Seeger Weiss has been named a finalist in seven categories in the National Law Journal’s 2026 Elite Trial Lawyers Awards, tied for the most of any firm in this year’s field. The firm’s finalist placements include: Plaintiff Law Firm of the Year Antitrust Class Action Governmental Representation Mass Torts Pharmaceutical Litigation Products Liability Being named […]

Read More
May 28, 2026
Seven Seeger Weiss Attorneys Named To The 2026 Lawdragon 500 Leading Global Litigators Guide

Seeger Weiss is pleased to announce that seven Seeger Weiss attorneys have been selected for inclusion in The 2026 Lawdragon 500 Leading Global Litigators guide. Congratulations to Christopher Seeger, Stephen Weiss, Parvin K. Aminolroaya, Ben Barnett, David R. Buchanan, Shauna Itri, and Jennifer Scullion, on this well-deserved recognition. Chris, Stephen, and Jennifer were awarded for […]

Read More